Keith Katkin, President and CEO at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 102,874 shares at $2.83 ($292K) on 2010-09-01, disclosed to the SEC on 2010-09-02.
Scheduled sale ($292k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.86 | 40,000 | $114K | 39.1% |
| 2 | $2.83 | 62,874 | $178K | 60.9% |
| Total | $2.84 avg | 102,874 | $292K | 100% |
| Filing → |
| SNDX | BUY | 2025-05-19 | $91K | — | Filing → |
| SNDX | SELL | 2022-10-07 | $1.5M | — | Filing → |
| SNDX | SELL | 2022-10-04 | $176K | — | Filing → |